CF
Congress trade
Rep. C Franklin (R-FL) sold $15K-$50K of Merck & Company, Inc. (MRK) stock
C Franklin, U.S. Representative (R-FL), disclosed a sale of Merck & Company, Inc. (MRK) stock worth $15K-$50K in a STOCK Act filing on Oct 12, 2023.
The trade happened on Sep 11, 2023, 31 days before it was made public.
MRK has moved +32.9% since the trade date, from $108.60 to $144.30 (Oct 2, 2026 close).
- Traded
- Sep 11, 2023
- Disclosed
- Oct 12, 2023
- Filing delay
- 31 days
- Price since
- +32.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (21)
- SellCSCO$50K-$100KOct 12, 2023
- SellGOOG$50K-$100KOct 12, 2023
- SellAAPL$15K-$50KOct 12, 2023
- SellBRK.B$15K-$50KOct 12, 2023
- SellDFS$15K-$50KOct 12, 2023
- SellHD$15K-$50KOct 12, 2023
- SellJNJ$15K-$50KOct 12, 2023
- SellJPM$15K-$50KOct 12, 2023
- SellMCD$15K-$50KOct 12, 2023
- SellMSFT$15K-$50KOct 12, 2023
- SellNEE$15K-$50KOct 12, 2023
- SellPEP$15K-$50KOct 12, 2023
- SellPG$15K-$50KOct 12, 2023
- SellSBUX$15K-$50KOct 12, 2023
- SellUNH$15K-$50KOct 12, 2023
- SellUPS$15K-$50KOct 12, 2023
- SellV$15K-$50KOct 12, 2023
- SellWMT$15K-$50KOct 12, 2023
- SellIJR$1K-$15KOct 12, 2023
- SellPFE$1K-$15KOct 12, 2023
More MRK insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.